Sarah Butler

Former President, Life Sciences @Truepill, Former SVP @Avalere. Passionate about health policy, digital health, & innovation. Tweets are my own.

[Sarah Butler @SarahButlerMHS]

Team @truepill_rx took over Austin this week. Lots of great things on the horizon for #lifesciences #digitalhealth #Telemedicine #diagnostics #pharmacy

[Bob Wachter @Bob_Wachter]

Tragically, we've all become numb to Covid's death toll. Sometimes it takes a tangible comparison to shake us out of complacency.
I had such a moment today, when Covid deaths in the U.S. hit 875,000. That, as it happens, is the population of my city, San Francisco. Staggering.

[Sarah Butler @SarahButlerMHS]

Excited to be part of the team making this happen!

[Truepill @truepill_rx]

4/4 - We're proud to share our latest COVID-19 solution, helping insurers and commercial health plans quickly and easily meet new government reimbursement requirements, increasing access to over-the-counter, at-home COVID-19 tests. https://t.co/NvxxU6vBiS

[Seung Min Kim @seungminkim]

This graphic from the @WSJ is incredibly helpful

[Sarah Butler @SarahButlerMHS]

@Merck has formally requested @US_FDA emergency use authorization (EUA) for its Molnupiravir, an oral antiviral medicine for the treatment of #COVID19 Clinical trial results show this therapy can decrease hospitalizations and death by ~50%

[Sarah Butler @SarahButlerMHS]

As a mother of a 6 year old, I am absolutely thrilled that @pfizer has officially filed with @US_FDA for Emergency Use Authorization for its #COVID19 vaccine! Hoping it won’t be too long before my 3 year old can’t get vaccinated as well!

[Pfizer Inc. @pfizer]

UPDATE: We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12.

[Sarah Butler @SarahButlerMHS]

FDA Announces AdComm for COVID Vaccines for Children - in anticipation of receiving a request from Pfizer to amend its EUA to allow use of its #covidvaccine in children 5 to 11 FDA is scheduling a meeting on Oct. 26!

[Andy Slavitt @ASlavitt]

BREAKING: FDA approves Pfizer vaccine booster for people over 65 and those at risk of serious illness.

More here in a minute.

1/

[Sarah Butler @SarahButlerMHS]

The #COVID19 pandemic had disproportionate impacts on mortality by race and ethnicity of #Medicare enrollees. Mortality rates increased by 1.5 to 3 times among ethnic and racial minorities. @avalerehealth
Read more: https://t.co/Rj3wOnaSxt

[Sarah Butler @SarahButlerMHS]

Today is my last day as a resident of DC. Making a move to Seattle - I am so grateful to work for a company that enables me to make decisions that are best for me and my family without compromising my potential with the organization. Thank you! @avalerehealth @InovalonInc

[Drug Channels @DrugChannels]

Good op-ed by Gillian Woollett @avalerehealth on Semglee, the first interchangeable biologic

The high-list/high-rebate model will be a significant issue for Semglee's success or failure --and has implications for 2023 (and Humira)

https://t.co/ZHL7QhA0qH

@statnews

[Sarah Butler @SarahButlerMHS]

Looking forward to today's webinar focused on how Life Sciences companies can prepare for the post-pandemic environment!
https://t.co/C1ATC4HBle

[Sarah Butler @SarahButlerMHS]

#Digitalhealth and #telehealth remain of interest for healthcare investors. @FierceHealth reports that VC funding reached $15B in the first part of the year.

Read more: https://t.co/AxRkpcl8Kt

[Sarah Butler @SarahButlerMHS]

What can be done to shorten the diagnostic journey for patients with #rarediseases? An @AvalereHealth white paper highlights technology-driven solutions.

[Avalere (page inactive) @avalere]

For those looking to use technology solutions to shorten the diagnostic journey for as many #raredisease patients as possible, a new #AvalereHealth white paper identifies how to make progress in addressing the complex barriers.

Read the white paper: https://t.co/4X1b45AKMA

[Sarah Butler @SarahButlerMHS]

Not many fireworks out here in the country but we did manage to make the flag cake! Happy 4th!

[Matt Perron @mperron1]

We look forward to seeing all of our client partners, industry friends & colleagues at #Inovalon’s 14th Annual ScriptMed Conference. We will be hosting in person in South Beach, Florida November 7th-9th . We will have our best speakers yet and an exciting set of events. Join us!

[Sarah Butler @SarahButlerMHS]

#AvalereExperts Jay Jackson and Megan Olsen talk about the future of cell and gene therapy (#CGT) and how more therapies on the market impact payers in our latest #AvalereVoice episode.

Watch the video here: https://t.co/F0vd86GKmu

[Sarah Butler @SarahButlerMHS]

How can #pharma companies integrate #healthequity? Our #AvalereInsight details six potential areas for engagement.

[Avalere (page inactive) @avalere]

Our latest #AvalereInsight details innovative approaches for manufacturers to expand their footprint and further invest in #healthequity.

Read more from our #AvalereExperts: https://t.co/WxpgcMFirJ #pharma

[Sarah Butler @SarahButlerMHS]

An analysis of @icer_review verdicts on cell & gene therapies indicates the institute's reviewers have deemed more than half to be cost-effective. #CGT

Read more from @FiercePharma: https://t.co/oLlrXVzx9m